Know Cancer

or
forgot password

Randomized Trial of Exercise Training in Postmenopausal Patients With Hormone-receptor Positive Breast Cancer Undergoing Treatment With Aromatase Inhibitors


N/A
N/A
N/A
Open (Enrolling)
Female
Physical Activity

Thank you

Trial Information

Randomized Trial of Exercise Training in Postmenopausal Patients With Hormone-receptor Positive Breast Cancer Undergoing Treatment With Aromatase Inhibitors


Inclusion Criteria:



- Signed informed consent

- Postmenopausal women with hormone receptor positive breast cancer (as defined by HR
>= ++ and/or PR >= ++) who are treated with aromatase inhibitors

- ECOG performance status <= 2

- all age groups

Exclusion Criteria:

- Pathologic ergometry

- Uncontrolled diabetes mellitus

- Uncontrolled hypertension

- COPD > II

- Active opportunistic infection

- NYHA heart failure III or IV

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

Individual maximum power output in watt (Pmax) on a bicycle ergometer after 6 months of controlled or unobserved physical activity.

Outcome Time Frame:

after 6 months

Safety Issue:

No

Principal Investigator

Richard Greil, Prof.Dr.

Investigator Role:

Study Director

Investigator Affiliation:

Arbeitsgemeinschaft medikamentoese Tumortherapie

Authority:

Austria: Ethikkommission

Study ID:

AGMT_BC_Sports

NCT ID:

NCT01384838

Start Date:

June 2011

Completion Date:

April 2014

Related Keywords:

  • Physical Activity
  • breast cancer
  • physical activity
  • sports
  • exercise
  • Breast Neoplasms

Name

Location